Dianthus Therapeutics DNTH Business Segments
| FY'24 | ||
|---|---|---|
| Research And Development Expense by Product | ||
| Discovery Expenses | $2.12M+48.4% | |
| Personnel And Related Costs | $20.15M+112% | |
| General And Administrative Expense by Product | ||
| Other Costs | $9.43M+43.8% | |
| Personnel And Related Costs | $8.36M-12.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Dianthus Therapeutics break its business down?
- Dianthus Therapeutics (DNTH) reports research and development expense by product across 4 parts — Discovery Expenses, Other Costs, Personnel And Related Costs and Share Based Compensation Expense. Each is extracted from the segment footnotes and tracked over time.
- Where does Dianthus Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Dianthus Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.